Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes
移植后采用TP53双链测序进行微小残留病(MRD)监测,并结合APR-246+阿扎胞苷维持治疗,可预测预后。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017742
Sallman, David A; McLemore, Amy F; Komrokji, Rami; Elmariah, Hany; Kuykendall, Andrew T; Bejanyan, Nelli; Chan, Onyee; Faramand, Rawan; Pidala, Joseph; Yoder, Sean J; Perez, Lia; Nishihori, Taiga; Padron, Eric; Fernandez, Hugo; Lancet, Jeffrey E; Mishra, Asmita